Pith. sign in

REVIEW

Modeling competition between two pharmaceutical drugs using innovation diffusion models

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 1602.02898 v1 pith:6XIZXFFJ submitted 2016-02-09 stat.AP

classification stat.AP
keywords competitiondiffusiondrugsinnovationknowledgemarketmodelingpharmaceutical
verification ladder T0 review T1 audit T2 compute T3 formal
0 comments
read the original abstract

The study of competition among brands in a common category is an interesting strategic issue for involved firms. Sales monitoring and prediction of competitors' performance represent relevant tools for management. In the pharmaceutical market, the diffusion of product knowledge plays a special role, different from the role it plays in other competing fields. This latent feature naturally affects the evolution of drugs' performances in terms of the number of packages sold. In this paper, we propose an innovation diffusion model that takes the spread of knowledge into account. We are motivated by the need of modeling competition of two antidiabetic drugs in the Italian market.

Discussion (0). Continue with ORCID to comment.

Pith tools